1 / 15

Top 10 Stocks To Picks in 2021 From Century Financial

Know Top 10 Stocks To Picks in 2021.<br><br>As UAEs leading financial consultancy firm with 3 decades of market presence, Century Financial offers investment solutions, CFD trading on currencies, indices, commodities in global financial markets to both local and expatriate clients in Dubai.

Download Presentation

Top 10 Stocks To Picks in 2021 From Century Financial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Century Top 10 Picks 2021 21 January 2021 www.century.ae

  2. Disclaimer Century Financial Consultancy LLC ("CFC") is Limited Liability Company incorporated under the Laws of UAE and is duly licensed and regulated by the Emirates Securities and Commodities Authority of UAE (SCA). This document is a marketing material and is for informational purposes only and must not be construed to be an advice to invest or otherwise in any investment or financial product. CFC does not guarantee as to adequacy, accuracy, completeness or reliability of any information or data contained herein and under no circumstances whatsoever none of such information or data be construed as an advice or trading strategy or recommendation to deal (Buy/Sell) in any investment or financial product. CFC is not responsible or liable for any result, gain or loss, based on this information, in whole or in part. Please carefully read full disclosure mentioned below.

  3. Top picks 2021 A Quick Glance Bloomberg Analyst Recommendations Price on 20/01/21 Market cap in Billions Buy Hold Sell 52 Week Low 52 Week High Instrument Name $246.7 Teladoc Health Inc $35.8 20 11 0 $93.6 $253.0 $53.2 Draftkings Inc $20.8 18 9 1 $10.6 $64.2 $64.4 Digital turbine Inc $5.7 4 2 0 $3.5 $65.1 $150.0 Toyota Motor Corp ADR $244.7 2 1 0 $108.0 $156.3 $47.0 Zoominfo Technologies Inc $18.3 13 4 0 $30.8 $64.4 $77.9 eHealth Inc $1.84 11 2 0 $60.4 $152.2 $45.6 Azure Power Global $2.2 5 1 0 $11.8 $53.6 $5.6 Nomura Holdings Inc (ADR) $18.0 3 7 1 $3.6 $5.8 $13.7 Clover Health Investments Corp $6.1 1 0 0 $9.9 $17.5 $32.0 Yelp Inc $2.4 3 15 2 $12.9 $36.9 Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  4. Price Chart Analyst rating Buy 20 Hold 11 Sell 0 Security name Teladoc Health Inc Last price on 20thJan $246.7 52 week low $93.6 52 week high $253.0 Teladoc Health Market Cap in Billions Shares outstanding (million) $35.8 Teladoc Health is a virtual health pioneer. The company provides internet access to healthcare professionals 24/7 for patients around the world. 144.96 Average 30 Day volumes 2857482 Not surprisingly, the demand for the company's services has dramatically increased in 2020, the year of COVID-19. The coronavirus has highlighted the need to ofer digital and remote healthcare services, particularly during crises. Teladoc was able to seize the moment, as it had already built a strong baseline product ofering before the pandemic hit. As a result, shares have nearly quadrupled over the past year. Total telemedicine visits hit 2.8 million in the second quarter, up 203% from the prior-year period. But it's not like Teladoc was a slouch before COVID- 19. Assuming $1 billion in annual sales in 2020, Teladoc's compound annual growth rate since 2013 is 75%. Beta 0.4 Forward Price to Sales 20.1 x x Forward EV to Sales 18.2 Estimated Revenue Growth % 80% The thing is, telemedicine is a win for the entire healthcare treatment chain, with physicians able to attend more patients, insurers paying less in fees than an in-ofce visit, and the patient having the convenience of consulting with a physician from home. Teladoc recently completed the merger with healthcare solutions provider Livongo Health in a cash and-stock deal. Livongo aggregates data for patients with chronic illnesses and, using artificial intelligence as an aid, sends its members tips and nudges to incite behavioral changes. Currently, Livongo Health has more than 410,000 diabetes members and has been at least doubling its member count on a year-over-year basis. With Teladoc and Livongo now one company, it's going to be a telemedicine/personalized solutions powerhouse. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  5. Price Chart Analyst rating Buy 18 Hold 9 Sell 1 Security name Draftkings Inc Last price on 20thJan $53.2 52 week low $10.6 52 week high $64.2 Draftkings Inc Market Cap in Billions Shares outstanding (million) $20.8 The leader in fantasy sports wagering and a rising player in more traditional sportsbook gambling saw its revenue climb by 42% in its latest quarter, despite the new normal with shorter seasons and so many games forbidden amid COVID-19 outbreaks. 391.71 Average 30 Day volumes 16477687 The year ahead should get far more predictable, as a packed calendar for the winter/early Spring, including college football championships, March Madness, and the Super Bowl should drive increasing amounts of viewership and mood to gamble on these events. Forward Price to Sales 26.7 x Forward EV to Sales 23.0 x Estimated Revenue Growth % 54% In the meantime, DraftKings did not lose sight of its opportunity to grow its access. DraftKings has signed recent partnerships that make it the exclusive sportsbook provider for ESPN, Turner Sports, and individual leagues like the PGA. All this attention will make it that much easier to ramp up its more lucrative online sportsbook operations as regulations on gambling continue to loosen up in the months and years ahead. Amid the ongoing public health crisis, state budgets are getting worse, and as a result, new states are considering passing legislation to allow online sports betting and iGaming. This could benefit Draftkings consid- erably as data shows that once sports gambling is legalized in a particu- lar area, revenue growth ramps up very quickly. By fall of this year DraftKings' sportsbooks will be operational for ~35% of the U.S. popula- tion versus just ~14% in 2020. Therefore, near-term revenue multiples are less meaningful as the potential revenue explosion for Draftkings is massive as more of the U.S. opens up. Pent-up demand for sports gambling, new tide towards legalization and direct partnerships with the biggest names in sports can carry DraftKings to a scale far beyond its current situation. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  6. Price Chart Analyst rating Buy 4 Hold 2 Sell 0 Security name Digital turbine Inc Last price on 20thJan $64.4 52 week low $3.5 52 week high $65.1 Digital Turbine Market Cap in Billions Shares outstanding (million) $5.7 Digital Turbine holds a unique place in the mobile phone ecosystem as it is the only company embedded into the Android operating system to allow for app downloading. The company sits between major carriers, such as AT&T and Verizon, and companies, such as Netflix and Amazon, that want their apps pre-installed on Android phones. With 6,000 apps being added per day to the Android platform, demand for the limited number of app slots has only increased. Moreover, given the increase in time spent on mobile phone, both the number of devices and revenue per device continue to improve for Digital Turbine. 88.70 Average 30 Day volumes 3166936 Beta 1.6 Forward Price to Sales 18.2 x Additionally, the recent integration of Mobile Posse which has brought T-Mobile users and greater scale to the platform is a big positive for the company x Forward EV to Sales 16.3 Estimated Revenue Growth % 101% Mobile Posse provides media & advertising solutions for operator & OEM partners while delivering richer, more relevant content to end users. This is a content business that generates substantial recurring revenue over the life of the phone and is not as tied to activations/new phone sales as the historical app install business is. The company is positioned to benefit in the long run as Mobile Posse’s recurring revenue nature is attractive, and the envisioned cross selling synergies with will be a strong growth driver. Digital Turbine has had a fabulous run, yet there is a lot more gas in its tank. With the stock down 20% from the high, adding some position now could pay of in the long run as traditional ad spend transition towards the more data-driven solutions that this companies ofers. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  7. Price Chart Analyst rating Buy 2 Hold 1 Sell 0 Security name Toyota Motor Corp ADR Last price on 20thJan $150.0 52 week low $108.0 52 week high $156.3 Toyota Motor Corp- ADR Market Cap in Billions Shares outstanding (million) $244.7 Electric vehicle (EV) stocks have already had a stupendous run last year. In fact, exclusive EV players mostly outperformed internal combustion engine (ICE) companies. This is primarily because worldwide, there is tremendous pressure on auto manufacturers to trim CO2 emission. Moreover, Biden’s $2 trillion clean energy plan also lifted the energy sector in the US and is forecasted to have a ripple efect worldwide. To put things into perspective, EV sales across the globe are projected to grow 50% or more in 2021, compared to ICE’s expected sales growth of a meager 2% to 5%. EV penetration globally has also been projected at 4%, increasing to 31% by 2030. To match the evolving momentum of the sector, ICE car manufacturers are revamping and redesigning their upcoming lineup to create a competitive prototype for an electric model. 1631.50 Average 30 Day volumes 299970 Beta 0.7 Forward Price to Sales 0.9 x x Forward EV to Sales 1.5 Estimated Revenue Growth % 11% Toyota has hopped on the bandwagon of electric automobiles and is prepared to launch its first electric vehicle by the fourth quarter of 2021. The company intends to globally sell 5.5 million electric vehicles every year by 2025, this news has signaled a positive outlook and should increase price momentum along with supporting growing dividends that are currently at a 5-year CAGR of 2.91%. The Japanese automobile company has broadcasted that the electric car set to launch later this year, will introduce the first of its kind solid prototype battery which is less prone to fire hazards in comparison to the Lithium-ion batteries that are currently being used in electric cars. With tech safer than Lithium-ion batteries, fraction amount of charging time and double the output of a conventional battery, the performance of Toyota Motor Corp. is expected to be extraordinary Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  8. Price Chart Analyst rating Buy 13 Hold 4 Sell 0 Security name Zoominfo Technologies Inc Last price on 20thJan $47.0 52 week low $30.8 52 week high $64.4 ZoomInfo Technologies Market Cap in Billions Shares outstanding (million) $18.3 ZoomInfo is the number one cloud-based go-to-market intelligence platform that puts sales and marketing professionals in position to identify, connect, and engage with qualified prospects. 81.74 The company utilizes a team of research analysts, data scientists, artificial intelligence, and machine learning techniques to add to and enhance its database of 14M companies and 120M professionals. ZoomInfo guarantees the accuracy of its database, and its quality of the data is evidenced by the data that 40% of customers and 80% of enterprises who churn return within one year. Average 30 Day volumes 2314887 Forward Price to Sales 32.2 x Forward EV to Sales 31.8 x Estimated Revenue Growth % 29% The company reported a strong Q3 beat, with revenue growth accelerat- ing to 55% Y/Y (versus 18% in Q2, but was closer to ~30% on an adjusted basis). Multiple factors including new product cycles, along with focus on enterprise and international traction should continue to drive the growth for the company. The company has started selling a new sales engage- ment tool, called Engage, which has the potential to drive 20-30% price uplift per seat. COVID-19 has elevated the focus on digital go-to-market and lead generation, perhaps amplifying the trend which was already developing nicely for ZoomInfo. With companies getting a taste for higher-quality data and better tools to attract customers, its highly unlikely they would go back to a more laborious, less-efective process even in a covid-free world. ZoomInfo’s diferentiated and sticky technology, rapid revenue growth, a large TAM, and a strong financial profile make it a unique asset among software companies. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  9. Price Chart Analyst rating Buy 11 Hold 2 Sell 0 Security name eHealth Inc Last price on 20thJan $77.9 52 week low $60.4 52 week high $152.2 eHealth Inc Market Cap in Billions Shares outstanding (million) $2.0 The Medicare segment has grown considerably over the past couple of years, and the market for long term health care software will continue to grow at an increasing pace due to shortage of medical staf, changes in healthcare infrastructure and tech-based solutions in the sector. 25.90 Average 30 Day volumes 556536 Moreover, with Joe Biden set to take over the presidency reign and reinforce the afordable care act (ACA) that was suppressed by Donald Trump, the United States of America may experience a renewed importance for private health insurance shopping. Additionally, the COVID accelerated transition from in-person interactions to soft linkages will further boost revenue growth of online health care platforms and portals. Beta 1.1 Forward Price to Sales 2.8 x x Forward EV to Sales 2.2 Estimated Revenue Growth % 28% eHealth Inc (EHTH) is a private online platform that provides insurances for various group of end consumers: individuals, families and small businesses. The forum does not only act as an interface between insurance firms and customers but also enables individuals to research, compare and make and educated insurance purchase. The firm has benefitted during the slump of lockdown and the estimated earnings growth for 2020 is expected to be 1,444%, which is exponentially higher than the firm’s average 5-year growth rate of 63.8%. The firm is currently growing its marketing and tele sales capacity to further drive growth and expects an increase of 38% in online insurance applications in Q42020 in comparison to the last quarter. EHTH’s expected revenue for 2020 is between $630 million to $670 million in comparison to $506 million the previous year. Moreover, improvement in the loan to value ratio of the firm will enhance profitability further. With favorable political policies in 2021, and excessive incline towards soft interactions, EHTH has upside potential and encouraging returns. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  10. Price Chart Analyst rating Buy 5 Hold 1 Sell 0 Security name Azure Power Global Last price on 20thJan $45.6 52 week low $11.8 Azure Power Global 52 week high $53.6 Biden’s campaign to inject $2 trillion to the clean energy sector has lifted the energy sector in the US and is forecasted to have a ripple efect worldwide. India’s solar energy sector is forecasted to expand at >20% CAGR, 2020-25, signaling a long-awaited interest in the niche unexploit- ed market, especially for a developing country. This overturn is expected to generate a net positive return and may lead to an influx for asset buyers down the road. Market Cap in Billions Shares outstanding (million) $2.2 48.03 Average 30 Day volumes 274430 Beta 0.5 Azure Power Global, a leading solar power producer in India with a portfolio of over 7GWs of solar power assets is also the first Indian energy asset to be listed on the NYSE as Azure Power. With in-house engineering, acquirement and construction expertise, Azure manages to provide a solar power to diferent stretches of the country. Forward Price to Sales 9.41 x x Forward EV to Sales 12.67 Estimated Revenue Growth % 25% The upward trends in earnings are the core reason for the firm to be fit for a growth portfolio. Empirical research showcases a valid correlation between shifts in earnings estimate revisions and near-term stock price movements. For the year ending in March 2021, the firm forecasted an EPS of -$0.14, which indicates a YOY increase of 70.2%. Furthermore, shares of Azure Power have risen over 300% compared to Q42019, whereas SPX has only moved by 17.15% over the same time span. With a new management in place, the firm is experiencing a prolonged price recovery as the busines model gets fine-tuned and the approach to increasing growth achieves clarity. Momentum in earnings and share price, integrated with the oversight of a strong management in place, make Azure a fundamentally backed growth stock. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  11. Price Chart Analyst rating Buy 3 Hold 7 Sell 1 Security name Nomura Holdings Inc (ADR) Last price on 20thJan $5.6 52 week low $3.6 Nomura Holdings 52 week high $5.8 Nomura Holdings, Inc. is a Japan-based company mainly engaged in the securities, investment, and financial business to individuals, corpora- tions, and governments across the world. It operates through the following segments: Retail, Asset Management, Wholesale, and Merchant Banking. Market Cap in Billions Shares outstanding (million) $18.0 3233.56 Average 30 Day volumes 173437 Recent quarter pretax income for the wholesale segment, which serves corporations and institutional investors, came out at 65.5 billion yen, compared to 18.9-billion-yen last year. While the retail division posted a 22.8-billion-yen net profit for the three months, compared with 5.3 billion yen a year ago. Beta 0.8 Forward Price to Sales 1.25 x x Forward EV to Sales 26.59 Going forward profitability is expected to improve as the company plans to cut costs by about 140 billion yen by March 2022. Recently Nomura, posted its strongest Q-o-Q, profit in more than 17 years, lifted by the stake sale in its afliate Nomura Research Institute with a one-of profit of 73.3 billion yen. Estimated Revenue Growth % 17% The earnings growth for Nomura holdings in 2020 is estimated to be 129%, exceeding the negative 5-year average growth rate by 134.5%. Corporate demands for capital raising and business restructuring could provide opportunities for its investment banking unit over the time span of 2021. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  12. Price Chart Analyst rating Buy 1 Hold 0 Sell 0 Clover Health Investments Corp Security name Last price on 20thJan $13.7 52 week low $9.9 Clover Health Corporation 52 week high $17.5 Clover health investment corporation is a Preferred Provider Organiza- tion (PPO) and a Health Maintenance Organization (HMO) with a Medicare contract. Medicare Advantage plans have all the essentials like hospital coverage, doctor visits, and drug coverage including no-cost extras. Market Cap in Billions Shares outstanding (million) $6.1 440.70 CLOV went public via a merger with Social Capital Hedosophia Holdings Corp. III, a special purpose acquisition company (SPAC). The deal values Clover at $3.7 billion and includes up to $1.2 billion in cash proceeds, $400 million of which is coming through private investment in the public entity. The company has a positive outlook with a unique model in health insurance. Average 30 Day volumes 13985027 Clover Health MA Membership/Covered Lives are growing fast 2019A: 41,143 2021E: 273,000 2023E: 589,000 Palihapitiya, a former Facebook executive, has used blank-check firms to acquire several firms previously. The 1st SPAC, Social Capital Hedoso- phia, merged with Virgin Galactic (SPCE) in 2019; 2nd, Social Capital Hedosophia II (IPOB), leaned into a merger with Opendoor the same year. A recent one was, Social Capital Hedosophia Holdings V joined forces with SoFi in an $8.65 billion deal. The major upside of blank-check firms is that there is certainty on the amount being raised and the investor. Clover Health Revenues are growing fast 2019A: $462M 2021E: $880M 2023E: $1,723M Enterprise Value of $3,702B 4.2x 2021E Revenues 2.1x 2023E Revenues Chamath Palihapitiya with a successful track record of special purpose acquisition deals makes the success of the merger more likely. SPACs have experienced explosive growth this year amid unprecedented volatility brought on by the coronavirus pandemic. Total proceeds from SPACs have exceeded $40 billion this year, nearly tripling the levels from a year ago. CLOV currently has 57,000 members across seven states in the US, the deal will provide significant capital for the company to scale and improve health outcomes for seniors across the United States. The healthcare industry is expanding in demographics and growing quickly while over the coming years clover can substantially increase its market share. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  13. Price Chart Analyst rating Buy 3 Hold 15 Sell 2 Security name Yelp Inc Last price on 20thJan $32.0 52 week low $12.9 Yelp 52 week high $36.9 The global shutdown of dining at restaurants in March 2020, heavily impacted the online recommendation service. Yelp’s advertisement revenues took a major hit and the firm lost almost $24 million in the second quarter of 2020 as revenues dropped by 32% from the prior year. However, as economies opened, ad revenues doubled in the third quarter and Yelp’s business rebounded. Market Cap in Billions Shares outstanding (million) $2.4 74.00 Average 30 Day volumes 1367465 Ever since, the online review platform has been initiating changes in its business model by increasing the home and local services segment by incorporating plumber, gardener and electrician reviews. Beta 1.4 Forward Price to Sales 2.40 x Last year to support the protest for George Floyd, the business also added warnings on overly racist businesses in every vicinity. Additionally, in 2020, Yelp also introduced a new feature to report COVID health code violations for restaurants. These include reports on social distancing, availability of contactless menus, employees wearing masks and warnings on violations made. x Forward EV to Sales 1.95 Estimated Revenue Growth % 13% If the changes introduced continue to pay of, the share price may cross its 52-week high. The firm aims to reduce restaurant reviews to only a tenth of its business revenues. Yelp currently undervalued and is trading at only twice its estimated forward sales. With over $600 million in cash and a market cap of $2 billion, the firm has intentions of buyback stocks in 2021. Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

  14. Risks & Assumptions  Drawdowns in actual trading can be higher than the tested system and losses could be significant in the event of leverage.  Unforeseen events can lead to variation in performance from the tested trading strategy.  The tested result has been computed with price feeds available from Bloomberg.  The testing environment has not considered transaction or any other costs.  Trading indicators used for the purpose of testing has been provided by Bloomberg.  information or data in a study or simulation that would not have been known or available during the period being analyzed. This can lead to inaccurate results in the study or simulation.  Future price movements may not be exactly the same as the historical price movements and this could lead to variation in performance.  Testing can sometimes lead to over-optimization. This is a condition where performance results are tuned so high to the past they are no longer as accurate in the future.  between the expected price of a trade and the price at which the trade is actually executed.  Disclaimer: Century Financial Consultancy LLC ("CFC") is Limited Liability Company incorporated under the Laws of UAE and is duly licensed and regulated by the Emirates Securities and Commodities Authority of UAE (SCA). This document is a marketing material and is for informational purposes only and must not be construed to be an advice to invest or otherwise in any investment or financial product. CFC does not guarantee as to adequacy, accuracy, completeness or reliability of any information or data contained herein and under no circumstances whatsoever none of such information or data be construed as an advice or trading strategy or recommendation to deal (Buy/Sell) in any investment or financial product. CFC is not responsible or liable for any result, gain or loss, based on this information, in whole or in part. Please carefully read full disclosure mentioned below. PLEASE READ THE FOLLOWING TERMS AND CONDITIONS OF ACCESS FOR THE PUBLICATION BEFORE THE USE THEREOF. By use of the publication and continuing to access the publication, you accept these terms and conditions and undertake to be bound by the acceptance. CFC reserves the right to amend, remove, or add to the publication and Disclaimer at any time without any prior notice to you. Such modifications may be efective immediately or otherwise. Accordingly, please continue to review this Disclaimer whenever accessing, or using the publication. Your access of, and use of the publication, after modifications to the Disclaimer will constitute your acceptance of the terms and conditions of use of the publication, as modified. If, at any time, you do not wish to accept the content of this Disclaimer, you may not access, or use the publication. Any terms and conditions proposed by you which are in addition to or which conflict with this Disclaimer are expressly rejected by CFC and shall be of no force or efect. No information as given herein by CFC in this publication should be construed as an ofer, recommendation or solicitation to purchase or dispose of any securities/financial instruments/prod- ucts or to enter in any transaction or adopt any hedging, trading or investment strategy. The data/information contained in the publication is not designed to initiate or conclude any transaction. Neither this publication nor anything contained herein shall form the basis of any contract or commitment whatsoever. Distribution of this publication does not oblige CFC to enter into any transaction. The information in this document is not intended, by itself, to constitute independent, impartial or objective research or a recommendation from CFC and should not be treated as such. The content of this publication should not be considered legal, regulatory, credit, tax or accounting advice. Anyone proposing to rely on or use the information contained in the publication should independently verify and check the accuracy, completeness, reliability and suitability of the information and should obtain independent and specific advice from appropriate professionals or experts regarding information contained in this publication. CFC cannot be held responsible for the impact of any transactional costs or any taxes as may be applicable on transactions. Information contained herein is based on various sources, including but not limited to public information, annual reports and statistical data that CFC considers reliable. However, CFC makes no representation or warranty as to the accuracy or completeness of any report or statistical data made in or in connection with this publication and accepts no responsibility whatsoever for any loss or damage caused by any act or omission taken as a result of the information contained in this publication. References to any financial instrument or investment product does not imply that an actual trading market exists for such instrument or product. In publishing this document CFC is not acting in the capacity of a fiduciary or financial advisor. The report does not take into account the investment objectives, financial situations and specific needs of recipients. The recipient of this publication must make its own independent decisions regarding whether this communication and any securities or financial instruments mentioned herein, is appropriate in the light of its investment objectives, investment experience, financial situation, existing portfolio holdings and/or investment needs. Recipients will need to decide on their own as to whether or not the contents of this document are suitable for them. This document is a marketing material and has been prepared by individual(s), marketing and/or research personnel of CFC. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is purely a marketing communication. In this publication, any opinions, news, research, analysis, prices, or other information constitute is a general market commentary, and do not constitute the opinion or advice of CFC or any form of personal or investment advice. CFC neither endorses nor guarantees oferings of third party, nor is CFC responsible for the content, veracity or opinions of third-party speakers, presenters, participants or providers. CFC will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information. Charts, graphs and related data or information provided in this publication are intended to serve for illustrative purposes only. The information contained in this publication is prepared as of a particular date and time and will not reflect subsequent changes in the market or changes in any other factors relevant to their determination. All statements as to future matters are not guaranteed to be accurate. CFC expressly disclaims any obligation to update or revise any forward-looking statements to reflect new information, events or circumstances after the date of this publication or to reflect the occurrence of unanticipated events. The information in this communication cannot disclose everything about the nature and risks of the abovementioned data / information. This is not an exhaustive list of the risks involved, nor should it be regarded as ofering advice on the suitability of these investments for the recipient. All views expressed in all reports, analysis and documents are subject to change without notice. CFC may have issued other reports, analysis or other documents expressing diferent views from the contents hereof. Staf members/employees of CFC may provide/present oral or written market commentary or analysis to you that reflect opinions that are contrary to the opinions expressed in this research and may contain insights and reports that are inconsistent with the views expressed in this publication. Neither CFC nor any of its afliates, group companies, directors, employees, agents or representatives assume any liability nor shall they be made liable for any damages whether direct, indirect, special or consequential including loss of revenue or profits that may arise from or in connection with the use of the information provided in this publication. Information or data provided by means in this publication may have many inherent limitations, like module errors or lack accuracy in its historical data. Data included in the publication may rely on models that do not reflect or take into account all potentially significant factors such as market risk, liquidity risk, credit risk etc. CFC and its afliates reserve the right to act upon or use the contents hereof at any time, including before its publication herein. The use of our information, products and services should be on your own due diligence and you agree that CFC is not liable for any failure to achieve desired return on investment that is in any manner related to availing of services or products of CFC and use of our information, products and services. You acknowledge and agree that past investment performance is not indicative of the future performance results of any investment and that the information contained herein is not to be used as an indication for the future performance of any investment activity. Any prices provided in this document are indicative only and do not represent firm quotes as to either price or size. The value of any investment or income may go down as well as up. All investments involve an element of risk, including capital loss. This publication is being furnished to you solely for your information and neither it nor any part of it may be used, forwarded, disclosed, distributed or delivered to anyone else. You may not copy, reproduce, display, modify or create derivative works from any data or information contained in this publication. This document may not be published, circulated, reproduced, or distributed in whole or part to any other person (whether within or in a jurisdiction outside UAE) without the prior written consent of CFC. Declaration of the Financial Analyst The analyst(s) who prepared this report certifies that the opinions contained herein accurately and exclusively reflect his or her views. The Analyst further undertakes that he or she has taken reasonable care to maintain independence and objectivity in respect of the opinions herein. The analyst(s) who wrote this report does not hold securities in the Company mentioned in the report. The analyst(s) receives a fixed compensation from CFC. No part of his or her compensation was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this report. The business solicitation or marketing departments of CFC are separate and independent from the reporting line of the analyst(s). The analyst(s) confirms that he or she and his / her associates do not serve as directors or ofcers of the Company, and the Company or other third parties have not provided or agreed to provide any compensation or other benefits to the analyst(s) in connection with this report. An “associate” is defined as the spouse, parent or step-parent, or any minor child (natural or adopted) or minor step-child, of the analyst. Services ofered by CFC include products that are traded on margin and can result in losses that exceed deposits. Before deciding to trade on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Trading with leverage carries significant risk of losses and as such margin products are not suitable for every investor and you should ensure that you understand the risks involved and should seek independent advice from professionals or experts if necessary.

  15. Century Financial Level 6, Building 4, Emaar Square, Downtown, Dubai P.O. Box 65777, Dubai, United Arab Emirates Compiled by: Phone: +971 (4) 356 2800 Fax: +971 (4) 355 4630 Email: info@century.ae ARUN LESLIE - Chief Market Analyst DEEPA SACHANANDANI - Senior Research Analyst Date: 21th Jan, 2021 www.century.ae Data Source: Bloomberg Disclaimer: Our services include promotion and introduction of financial market products that are traded on margin and can result in losses that exceed deposits. Transactions or trades in the financial markets are very risky, and you should trade only with the capital you can afford to risk or lose. Before deciding on trading on margin products, you should consider your investment objectives, risk tolerance and your level of experience on these products. Margin products may not be suitable for everyone, and you should ensure that you understand the risks involved. Century Financial shall not be bound or liable for any transaction, result, gain or loss, in whole or in part. Past performance is not indicative of and does not guarantee future results. Please read the complete disclaimer carefully.

More Related